Karen Joynt Maddox, MD, MPH, explained the many ways cardiology's business models are starting to evolve. She also touched on a number of other topics, including AI and the power of prevention.

SCAI and HRS have collaborated on new guidelines designed to help clinicians make the safest, smartest treatment decisions possible.

Ultromics plans to use the new funds to help expand its presence throughout the United States. In addition, the company is focused on developing additional AI-enabled software offerings.

The minimally invasive operation, known as AVATAR, is performed through a small incision in the patient’s neck.

The first coronary DCB to gain FDA approval just received an additional reimbursement that could improve patient access. 

The interventional device, designed to perform both M-TEER and T-TEER, is at the center of two new studies published in EuroIntervention.

The company's automated insulin pump can now be used to treat more patients thanks to an expanded CE mark approval. Could updates from the FDA be next?

Toby Rogers, MD, PhD, noted that BASILICA is a fairly complex procedure. Using this advanced technology, however, could make it easier to perform and improve patient access.

The FDA thinks 24/7 fitness trackers from Boston-based Whoop should be regulated like medical devices. Whoop disagrees, however, and neither side appears to be changing its mind. 

The incident happened in January of this year, with attackers gaining access to the practice’s systems for five days before they were shut out. 

Despite numerous advances in scanner technology, many patients are being exposed to higher amounts of radiation during CT exams than in the past.